Literature DB >> 12055607

Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis.

K Shiva Kumar1, Jay Lefkowitch, Mark W Russo, Charles Hesdorffer, Milan Kinkhabwala, Sandip Kapur, Jean C Emond, Robert S Brown.   

Abstract

We report on a patient with primary AL amyloidosis who presented with progressive liver failure secondary to hepatic infiltration in the absence of significant extrahepatic involvement. Orthotopic liver transplantation was performed successfully. After an uneventful postoperative course, the patient developed evidence of significant recurrent amyloidosis requiring treatment. He then underwent stem cell transplantation 10 and 14 months after liver transplantation. After 28 months of follow-up posttransplantation, the patient continues to do well, with no clinical evidence of recurrent disease. This is the first reported patient with primary amyloidosis to undergo sequential liver and stem cell transplantation leading to resolution of the disease and only the second to undergo successful liver transplantation for this disorder.

Entities:  

Mesh:

Year:  2002        PMID: 12055607     DOI: 10.1053/gast.2002.33648

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Subacute liver failure secondary to amyloid light-chain amyloidosis.

Authors:  Theresa J Hydes; Richard J Aspinall
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

2.  Amyloidosis and subacute liver failure.

Authors:  Moby Joseph; Timothy J S Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

3.  MNGIE Syndrome: Liver Cirrhosis Should Be Ruled Out Prior to Bone Marrow Transplantation.

Authors:  Armin Finkenstedt; Melanie Schranz; Sylvia Bösch; Daniela Karall; Sabine Scholl Bürgi; Christian Ensinger; Mathias Drach; Johannes A Mayr; Andreas R Janecke; Wolfgang Vogel; David Nachbaur; Heinz Zoller
Journal:  JIMD Rep       Date:  2012-12-29

4.  Model systems and clinical applications of hepatic stem cells for liver regeneration.

Authors:  Min Zhang; Yan Zhong; Jun Chen
Journal:  Hepatol Int       Date:  2011-12-21       Impact factor: 6.047

5.  Rare case of acute on chronic hepatic failure in a patient with multiple myeloma-associated amyloidosis.

Authors:  Muzammil Muhammad Khan; Mamoon Ur Rashid; Waqas Ullah; Ishtiaq Hussain; Abu Hurairah
Journal:  BMJ Case Rep       Date:  2020-01-28

6.  Response of Bortezomib Chemotherapy in Hepatic Amyloidosis.

Authors:  Syed M Hasan; Nida N Ahmed; Zunirah Ahmed; Allan Seibert
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.